Send to

Choose Destination
Pharmacol Res. 2006 Dec;54(6):481-5. Epub 2006 Aug 7.

The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.

Author information

Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-901 87 Umeå, Sweden.

Erratum in

  • Pharmacol Res. 2007 Jan;55(1):80.


Inhibitors of the enzyme fatty acid amide hydrolase (FAAH), the principal enzyme involved in the metabolism of the endogenous cannabinoid anandamide, have potential utility in the treatment of disorders including inflammation and inflammatory pain. The carbamate compound URB597 (3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate) potently and selectively inhibits FAAH by forming a covalent bond with a key serine residue of the enzyme. Little is known as to the pH dependency of this inhibition. Using a preincubation time of 10min, URB597 inhibited rat brain anandamide hydrolysis with pI(50) values of 7.19+/-0.02 and 7.75+/-0.06 at pH 6 and 8, respectively. The inhibition was time-dependent, and second order rate constants of approximately 0.15x10(6)M(-1)min(-1) (pH 6) and approximately 1.2x10(6)M(-1)min(-1) (pH 8) could be estimated. In intact C6 glioma cells and using a preincubation time of 10min, URB597 inhibited the hydrolysis of 250nM [(3)H]AEA hydrolysis with pI(50) values of 5.58+/-0.07 and 6.45+/-0.07 at extracellular pH values of 6 and 8, respectively. Since tissue pH is affected by inflammation, these data would suggest that the pH selectivity of the inhibition can contribute to the potency of the compound in vivo.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center